老年女性血清FSH与骨密度、骨髓脂肪及体成分的关联
基于AGES-Reykjavik队列的观察性研究,在调整雌二醇和睾酮后,老年绝经后女性中血清FSH最高四分位组相比最低四分位组,脊柱整体骨密度和压缩强度指数更低,骨髓脂肪更高,体重、内脏脂肪、瘦体重和脂肪量更低;男性中FSH与任何结局均无关。
要点
- 老年绝经后女性FSH较高与脊柱骨密度降低和骨髓脂肪增加独立相关。
- 高FSH女性同时表现为体重、内脏脂肪、瘦体重和脂肪量降低。
- 男性中未观察到FSH与骨密度、骨髓脂肪或体成分的关联。
核心结论
- 老年绝经后女性FSH水平较高与骨髓脂肪更高、骨密度更低及脂肪和瘦体重更低相关,且独立于雌二醇和睾酮水平。
研究设计与样本
- 观察性队列研究,纳入AGES-Reykjavik研究的老年人,女性N=238,平均年龄81岁。
主要发现
- 女性FSH最高四分位组相比最低四分位组,脊柱整体骨密度低8.6%,脊柱压缩强度指数低34.8%,骨髓脂肪高8.4%。
- 女性FSH最高四分位组相比最低四分位组,体重低8.4%,内脏脂肪面积低17.6%,瘦体重低6.1%,脂肪量低11.9%(所有P<0.05)。
- 男性中FSH水平与任何结局均无关联。
临床怎么用
- 对老年绝经后女性,高FSH水平可作为骨密度降低和骨髓脂肪增加的风险提示指标。
局限性
- 原文指出需要纵向研究以更好理解 underlying mechanisms。
- 男性样本中未观察到关联,可能受样本量或人群特征限制(原文未明确说明)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Follicle-stimulating hormone (FSH) concentrations increase during the perimenopausal transition and remain high after menopause. Loss of bone mineral density (BMD) and gain of bone marrow adiposity (BMA) and body fat mass also occur during this time. In mice, blocking the action of FSH increases bone mass and decreases fat mass. OBJECTIVE: To investigate the associations between endogenous FSH levels and BMD, BMA, and body composition in older adults, independent of estradiol and testosterone levels. DESIGN, SETTING, AND PARTICIPANTS: Older adults from the AGES-Reykjavik Study, an observational cohort study. MAIN OUTCOME MEASURES: Areal BMD, total body fat, and lean mass were measured with dual-energy x-ray absorptiometry. Lumbar vertebral BMA was measured by 1H-magnetic resonance spectroscopy. Volumetric BMD and visceral and subcutaneous adipose tissue (VAT, SAT) areas were measured with quantitative computed tomography. The least squares means procedure was used to determine sex hormone-adjusted associations between quartiles of serum FSH and BMD, BMA, and body composition. RESULTS: In women (N = 238, mean age 81 years), those in the highest FSH quartile, compared with the lowest quartile, had lower adjusted mean spine integral BMD (-8.6%), lower spine compressive strength index (-34.8%), higher BMA (+8.4%), lower weight (-8.4%), lower VAT (-17.6%), lower lean mass (-6.1%), and lower fat mass (-11.9%) (all P < 0.05). In men, FSH level was not associated with any outcome. CONCLUSIONS: Older postmenopausal women with higher FSH levels have higher BMA, but lower BMD and lower fat and lean mass, independent of estradiol and testosterone levels. Longitudinal studies are needed to better understand the underlying mechanisms.
引用
- Veldhuis-Vlug AG, Woods GN, Sigurdsson S, et al. Serum FSH Is Associated With BMD, Bone Marrow Adiposity, and Body Composition in the AGES-Reykjavik Study of Older Adults. J Clin Endocrinol Metab. 2021. PMID: 33326040. doi:10.1210/clinem/dgaa922
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。